Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-05-30 @ 7:37 AM
Study NCT ID:
NCT07412535
Status:
COMPLETED
Last Update Posted:
2026-02-17
First Post:
2026-01-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Extended Platelet Rich Fibrin or Hyaluronate Enriched Xenografts for Horizontal Ridge Augmentation Via Subperiosteal Tunneling
Sponsor:
Mansoura University
Organization:
Study Overview
Official Title:
Extended Platelet Rich Fibrin or Hyaluronate Enriched Xenografts for Horizontal Ridge Augmentation Via Subperiosteal Tunneling
Status:
COMPLETED
Status Verified Date:
2026-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
E-PRF
Brief Summary:
Extended platelet rich fibrin or hyaluronate enriched xenografts will be used for horizontal maxillary ridge augmentation via subperiosteal tunneling to allow placement of dental implants six months later.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: